News Chart Vertex Pharmaceuticals Incorporated

Stocks

VRTX

US92532F1003

Pharmaceuticals

Delayed Nasdaq 16:00:00 2026-09-04 EDT			5-day change	1st Jan Change
546.12 ^USD	-2.12%		+0.82%	+20.46%

09-02	Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating	MT
09-01	Vertex Pharmaceuticals Incorporated Announces Chief Financial Officer Changes, Effective January 1, 2027	CI

8d9086813dcbab33eec168d.ltEJqoF0dAbBBs1rx1doBRLK52VZF-9opMZ-lHBbzG8.34BImM9EAmiHcqUP9A4raFqugFQ3YIQJ96UX3iEq-ljvgGb64001fvI-pg~c52d45e51dd6cb67d877a109a8acdf77